by Andreu Prados
Bacteria and fungi in the human gut microbiota may contribute to the underlying mechanisms of IBS, which means the latter can be explored as a potential target for IBS. This article explores what is known about the role of the gut microbiome and yeast probiotics in irritable bowel syndrome.
by Giada De Palma
The third edition of IBS DAYS 2022 provided current advances and a look to future therapeutic approaches on the rapidly advancing field of irritable bowel syndrome. This article summarizes major highlights on diet and gut microbiome interactions of relevance for IBS.
by Joël Doré
Little is known about the relationship between diet, the composition and function of the gut microbiota and clinical symptoms of IBS. New findings identify how IBS symptom severity is related to a higher intake of foods with poor nutritional quality and gut microbiome features at both subspecies level and metabolic pathways involved in carbohydrate metabolism.
by Andreu Prados
The low FODMAP diet has been shown to be effective in managing the symptoms of IBS as second-line dietary advice when healthy eating approaches have failed to reduce symptoms. However, this eliminative diet is not without its challenges, which can be overcome by following the advice found below.
by Rene van den Wijngaard
Abdominal pain affects a huge amount of people nowadays, though its underlying mechanisms are not always understood. New findings in mice and humans reveal that localized immune responses against harmless foods might be involved in persistent “functional” abdominal pain.
by GMFH Editing Team
Diet is becoming increasingly popular as a means of managing IBS symptoms. A new study in 95 adults with IBS examines diet-gut microbiota associations and concludes that baseline gut microbiota is not a good predictor of clinical response to a low FODMAP diet or probiotic intervention.
by GMFH Editing Team
The heterogeneity of cross-sectional IBS studies has limited elucidating the gut ecosystem’s overall involvement in the disease pathogenesis. New longitudinal research that integrates multi-omics, patient and gastrointestinal data reveals previously unidentified targets that accompany changes in IBS activity.
Irritable bowel syndrome is one of the most common disorders diagnosed by gastroenterologists. Peppermint oil, specific probiotics, psyllium supplementation, first-line IBS dietary advice, and a low FODMAP diet can aid in improving IBS symptoms.
Diet is one of the cornerstones for managing IBS. The study of mechanisms of action coupled with symptom-related data are valuable for understanding the role of exclusion diets in patients with IBS.
by GMFH Editing Team
A wide range of factors are involved in driving the onset of IBS, with certain food items considered important triggers. Learn more about the latest scientific evidence regarding dietary management of IBS in this narrative review.
